Devises / ATAI
ATAI: ATAI Life Sciences N.V
3.20
USD
0.38
(13.48%)
Le taux de change de ATAI a changé de 13.48% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 2.81 et à un maximum de 3.35.
Suivez la dynamique ATAI Life Sciences N.V. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ATAI Nouvelles
- WSJ The MAHA Movement Loves Psychedelics. Should Wall Street?
- Seeking Alpha Atai: Critical Study Win Sets Up Double Approval Shot For Psychedelics In TRD
- Investing atai Life Sciences stock rating reiterated at Buy by Aegis Capital
- Investing atai Life Sciences stock maintains Buy rating after positive Phase 2b results
- Investing atai Life Sciences stock price target raised to $12 by Canaccord on positive trial data
- Investing Cathie Wood’s ARK ETF adjusts portfolio, buys Tesla and ATAI stock
- Benzinga Nasdaq Dips 150 Points; US ISM Manufacturing PMI Rises In June - Aeva Technologies (NASDAQ:AEVA), ATAI Life Sciences (NASDAQ:ATAI)
- Benzinga Mesoblast, Atai Life Sciences, Melco Resorts & Entertainment And Other Big Stocks Moving Higher On Tuesday - Advance Auto Parts (NYSE:AAP), ATAI Life Sciences (NASDAQ:ATAI)
- Benzinga Atai Life Sciences And Merger Partner Set Up Psychedelic Depression Therapy With Encouraging Late-Stage Data - ATAI Life Sciences (NASDAQ:ATAI)
- Investing ATAI Life Sciences stock soars after positive Phase 2b depression drug results
- Investing atai Life Sciences secures $50 million in private placement funding
- Investing Beckley Psytech’s depression drug shows strong results in phase 2b trial
- Seeking Alpha Compass Pathways: Psychedelics Drug Data Sends Share Price South - Rating Downgrade (CMPS)
- Investing Lucid Capital Markets initiates coverage on atai Life Sciences stock
- Benzinga CrowdStrike, Asana And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Asana (NYSE:ASAN), ATAI Life Sciences (NASDAQ:ATAI)
- Investing H.C. Wainwright maintains buy rating on atai Life Sciences stock
- Investing ATAI Life Sciences stock soars on Beckley Psytech merger deal
- Investing atai Life Sciences to Participate in Upcoming Investor Conferences
- Investing atai reports positive phase 2a results for depression treatment
Range quotidien
2.81
3.35
Range Annuel
1.03
3.35
- Clôture Précédente
- 2.79
- Ouverture
- 2.82
- Bid
- 3.20
- Ask
- 3.50
- Plus Bas
- 2.81
- Plus Haut
- 3.35
- Volume
- 11.967 K
- Changement quotidien
- 13.48%
- Changement Mensuel
- 21.67%
- Changement à 6 Mois
- 116.22%
- Changement Annuel
- 106.45%
18 juillet, vendredi
12:30
USD
- Act
- 1.321 M
- Fcst
- 1.333 M
- Prev
- 1.263 M
12:30
USD
- Act
- 1.397 M
- Fcst
- 1.456 M
- Prev
- 1.394 M
12:30
USD
- Act
- 4.6%
- Fcst
- 7.0%
- Prev
- -9.7%
12:30
USD
- Act
- 0.2%
- Fcst
- -0.6%
- Prev
- -2.0%
14:00
USD
- Act
- 61.8
- Fcst
- 65.5
- Prev
- 60.7
14:00
USD
- Act
- 58.6
- Fcst
- 60.3
- Prev
- 58.1
14:00
USD
- Act
- 66.8
- Fcst
- 61.1
- Prev
- 64.8
14:00
USD
- Act
- 4.4%
- Fcst
- 5.7%
- Prev
- 5.0%
14:00
USD
- Act
- 3.6%
- Fcst
- 3.8%
- Prev
- 4.0%
17:00
USD
- Act
- 422
- Fcst
- Prev
- 424
17:00
USD
- Act
- 544
- Fcst
- Prev
- 537
19:30
USD
- Act
- 40.7 K
- Fcst
- Prev
- 39.6 K
19:30
USD
- Act
- 59.4 K
- Fcst
- Prev
- 58.5 K
19:30
USD
- Act
- 213.1 K
- Fcst
- Prev
- 203.0 K
19:30
USD
- Act
- 162.4 K
- Fcst
- Prev
- 209.4 K
19:30
USD
- Act
- -167.8 K
- Fcst
- Prev
- -140.0 K
19:30
USD
- Act
- 0.5 K
- Fcst
- Prev
- 0.3 K
19:30
USD
- Act
- -129.5 K
- Fcst
- Prev
- -141.8 K
19:30
USD
- Act
- -74.1 K
- Fcst
- Prev
- -87.8 K
19:30
USD
- Act
- 15.3 K
- Fcst
- Prev
- 38.1 K
19:30
USD
- Act
- -65.5 K
- Fcst
- Prev
- -61.8 K
19:30
USD
- Act
- 34.9 K
- Fcst
- Prev
- 31.2 K